Q4 2024 Earnings Call Transcript March 7, 2025 Operator: Good morning, and welcome to the Molecular Partners Fourth Quarter ...

Before diving into the highlights '24, we did put on the 20 years Molecular Partners logo because it is our ... This number is clearly volatile by design. And this year, I think we, as I said ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on Sanofi (SNYNF – Research Report), with a price target of €100.00. The company’s shares closed ...

Berenberg Bank analyst Luisa Hector maintained a Buy rating on Sanofi (SNY – Research Report) yesterday and set a price target of $63.00. The company’s shares closed yesterday at $57.70.

When the newly formed ISU Brew Lab needed branding to market, label and sell their product, they looked no further than ISU’s ...

Sanofi (NASDAQ:SNY) said on Thursday that it is discontinuing the late-stage trial for its vaccine to prevent E. coli bacteria infection as it failed to demonstrate sufficient efficacy. The ...

A year and a half after Sanofi swooped in on Johnson & Johnson’s dismantled vaccines unit to pick up an E. coli candidate, the asset has failed its phase 3 trial. A scheduled review by the study ...

There are plenty of crafty details in Apple TV's hit series, Severance, but if you're a design fan that mysterious Lumon logo may have caught your eye. On the surface, it's the perfect unassuming ...

The governing body of women's tennis has a new logo, but its future in women's sports will not be defined by color schemes.

In ulcerative colitis, duvakitug led to clinical remission in up to 48% of patients, with placebo-adjusted rates of 27% at the highest dose. In Crohn's disease, duvakitug achieved endoscopic ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...